388 related articles for article (PubMed ID: 30874880)
1. Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups.
Zhuo EH; Zhang WJ; Li HJ; Zhang GY; Jing BZ; Zhou J; Cui CY; Chen MY; Sun Y; Liu LZ; Cai HM
Eur Radiol; 2019 Oct; 29(10):5590-5599. PubMed ID: 30874880
[TBL] [Abstract][Full Text] [Related]
2. Differences in Radiomics Signatures Between Patients with Early and Advanced T-Stage Nasopharyngeal Carcinoma Facilitate Prognostication.
Wu S; Li H; Dong A; Tian L; Ruan G; Liu L; Shao Y
J Magn Reson Imaging; 2021 Sep; 54(3):854-865. PubMed ID: 33830573
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
[TBL] [Abstract][Full Text] [Related]
4. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma.
Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y
EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358
[TBL] [Abstract][Full Text] [Related]
6. MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma.
Ming X; Oei RW; Zhai R; Kong F; Du C; Hu C; Hu W; Zhang Z; Ying H; Wang J
Sci Rep; 2019 Jul; 9(1):10412. PubMed ID: 31320729
[TBL] [Abstract][Full Text] [Related]
7. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
[No Abstract] [Full Text] [Related]
8. Machine Learning Analysis of Image Data Based on Detailed MR Image Reports for Nasopharyngeal Carcinoma Prognosis.
Cui C; Wang S; Zhou J; Dong A; Xie F; Li H; Liu L
Biomed Res Int; 2020; 2020():8068913. PubMed ID: 32149139
[TBL] [Abstract][Full Text] [Related]
9. Multimodality radiomics analysis based on [
Xu H; Lv W; Zhang H; Yuan Q; Wang Q; Wu Y; Lu L
Eur Radiol; 2023 Oct; 33(10):6677-6688. PubMed ID: 37060444
[TBL] [Abstract][Full Text] [Related]
10. MRI-based radiomics models can improve prognosis prediction for nasopharyngeal carcinoma with neoadjuvant chemotherapy.
Zeng F; Lin KR; Jin YB; Li HJ; Quan Q; Su JC; Chen K; Zhang J; Han C; Zhang GY
Magn Reson Imaging; 2022 May; 88():108-115. PubMed ID: 35181470
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
12. Radiomic feature repeatability and its impact on prognostic model generalizability: A multi-institutional study on nasopharyngeal carcinoma patients.
Zhang J; Lam SK; Teng X; Ma Z; Han X; Zhang Y; Cheung AL; Chau TC; Ng SC; Lee FK; Au KH; Yip CW; Lee VH; Han Y; Cai J
Radiother Oncol; 2023 Jun; 183():109578. PubMed ID: 36822357
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.
Lv W; Yuan Q; Wang Q; Ma J; Feng Q; Chen W; Rahmim A; Lu L
Mol Imaging Biol; 2019 Oct; 21(5):954-964. PubMed ID: 30671740
[TBL] [Abstract][Full Text] [Related]
15. A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma.
Sun MX; Zhao MJ; Zhao LH; Jiang HR; Duan YX; Li G
Radiat Oncol; 2023 Apr; 18(1):67. PubMed ID: 37041545
[TBL] [Abstract][Full Text] [Related]
16. Development of MRI-Based Radiomics Model to Predict the Risk of Recurrence in Patients With Advanced High-Grade Serous Ovarian Carcinoma.
Li HM; Gong J; Li RM; Xiao ZB; Qiang JW; Peng WJ; Gu YJ
AJR Am J Roentgenol; 2021 Sep; 217(3):664-675. PubMed ID: 34259544
[No Abstract] [Full Text] [Related]
17. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery.
Tan Y; Zhang ST; Wei JW; Dong D; Wang XC; Yang GQ; Tian J; Zhang H
Eur Radiol; 2019 Jul; 29(7):3325-3337. PubMed ID: 30972543
[TBL] [Abstract][Full Text] [Related]
18. Subregional Radiomics Analysis of PET/CT Imaging with Intratumor Partitioning: Application to Prognosis for Nasopharyngeal Carcinoma.
Xu H; Lv W; Feng H; Du D; Yuan Q; Wang Q; Dai Z; Yang W; Feng Q; Ma J; Lu L
Mol Imaging Biol; 2020 Oct; 22(5):1414-1426. PubMed ID: 31659574
[TBL] [Abstract][Full Text] [Related]
19. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
[TBL] [Abstract][Full Text] [Related]
20. Nomogram Based on Clinical and Radiomics Data for Predicting Radiation-induced Temporal Lobe Injury in Patients with Non-metastatic Stage T4 Nasopharyngeal Carcinoma.
Bin X; Zhu C; Tang Y; Li R; Ding Q; Xia W; Tang Y; Tang X; Yao D; Tang A
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e482-e492. PubMed ID: 36008245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
